检索

Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta

Orlov S., Dvorakovskaya I., Mosin I., Stel'makh L., Gorokhov A., Martynenko O., Poltoratskiy A.

卷 11, 编号 3 (2009)

Gertseptin: mekhanizm deystviya

Imyanitov E.

Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei

Khokhlova S., Romanov I., Gorbunova V., Matyakin E.

卷 9, 编号 2 (2007)

Sovremennaya taktika ad\"yuvantnoy lekarstvennoy terapii bol'nykh operabel'nym (rannim) rakom molochnoy zhelezy

Perevodchikova N.

Nekotorye prognosticheskie faktory pri sovremennoy terapii khronicheskogo limfoleykoza

Byalik T., Grivtsova L., Karseladze A., Zagoskina T., Bessmel'tsev S., Volkova M.

卷 7, 编号 3 (2005)

Rol' noveyshikh tekhnologiy v endoskopicheskoy diagnostike i otsenke effektivnosti lecheniya limfom zheludka

Malikhova O., Poddubnyy B., Kuvshinov Y., Frolova I.

卷 26, 编号 4 (2024)

The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report

Slashchuk K., Reinberg M., Serzhenko S., Sheremeta M., Nikiforovich P.

(Rus)

卷 26, 编号 1 (2024)

Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review

Sultanbaev A., Kolyadina I., Gilyazova I., Nasretdinov A., Musin S., Sultanbaeva N., Menshikov K.

(Rus)

卷 25, 编号 3 (2023)

Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis

Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.

(Rus)

Prospects for the treatment of neurofibromatosis type 1: A review

Mustafin R.

(Rus)

卷 23, 编号 3 (2021)

ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia

Bialik T., Vorob'ev V., Ionin V., Ysebaert L., Kaplanov K., Mendeleeva L., Nikitin E., Ptushkin V., Samoilova O., Stadnik E.

(Rus)

Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review

Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.

(Rus)

卷 22, 编号 3 (2020)

Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up

Ognerubov N., Antipova T., Gumareva G.

(Rus)

卷 22, 编号 1 (2020)

Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial

Levashov A., Zagidullina S., Stroganova A., Khochenkov D., Ryzhova M., Gorelyshev S., Kadirov S., Babelyan S., Grigorenko V., Sidel’nikov D., Subbotina N., Daylidite V., Mentkevich G.

(Rus)

卷 20, 编号 4 (2018)

Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?

Dadyev I., Davydov M., Shogenov M., Abdullaev A., Ibraev M., Filatov A.

(Rus)

卷 18, 编号 2 (2016)

Dural non-Hodgkin’s lymphomas

Babicheva L., Baikov V., Leenman E., Vinogradova Y., Ilyin N., Ryabchikova V., Poddubnaya I.

(Rus)

卷 17, 编号 4 (2015)

Modern possibilities of targeted therapy in metastatic colorectal cancer

Gorbunova V.

卷 16, 编号 3 (2014)

Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib

Smolin A., Gorbacheva A.

卷 15, 编号 4 (2013)

Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

Klimenko A., Ivanov S.

卷 15, 编号 2 (2013)

Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases

Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.

Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy

Artamonova E.

卷 11, 编号 2 (2009)

Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom

Orlova R., Tyukavina N.

卷 10, 编号 1 (2008)

8 let nadezhdy: novye dannye issledovaniya ATAS

卷 9, 编号 1 (2007)

Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?

Ptushkin V.

Limfoma Khodzhkina: prognosticheskie priznaki segodnya

Demina E.

卷 7, 编号 2 (2005)

Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga

Karakhan V., Aleshin V., Fu R., Krat V.

卷 26, 编号 1 (2024)

Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study

Levashov A., Zagidullina S., Valiev T., Stroganova A., Khochenkov D., Grigorenko V., Mikhaylova E., Tyurina E., Ryzhova M., Horielyshev S., Kadirov S., Polyakov V.

(Rus)

卷 25, 编号 4 (2023)

Radiation injuries of organs and tissues: mechanisms of occurrence, methods of prevention and treatment: A review

Balaeva D., Romanov D., Trofimova O., Gadzhibabaeva Z., Gorchak Y., Gariaev G.

(Rus)

The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review

Rykov I., Chubenko V.

(Rus)

卷 23, 编号 4 (2021)

Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer

Radzhabova Z., Kotov M., Girshovich M., Ponomareva O., Tkachenko E., Mitrofanov A., Radzhabova M., Levchenko E.

(Rus)

Modern radiation therapy in part of treatment primary mediastinal (thymic) B-large cell lymphoma (results of 131 patients treated at N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation)

Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma

Ignatova A.

(Rus)

卷 22, 编号 1 (2020)

ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution

Poddubnaya I., Al-Radi L., Byalik T., Kaplanov K., Molostvova V., Nikitin E., Pospelova T., Ptushkin V., Samoilova O., Stadnik E., Tumyan G.

(Rus)

卷 20, 编号 4 (2018)

Trofimova O., Zavodnova I., Tumyan G., Pryamikova Y., Volkova N., Zaichenko O., Nazarenko A.

(Rus)

卷 19, 编号 2 (2017)

The treatment of patients with advanced lung cancer associated with EGFR mutation

Bolotina L.

(Rus)

卷 18, 编号 1 (2016)

Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy

Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.

(Rus)

卷 17, 编号 2 (2015)

The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients

Frank G., Ilatovskaia M., Andreeva I., Zavalishina L.

卷 16, 编号 4 (2014)

Keratoacanthoma: possible management approaches. Case reports

Teterin K., Kizhaev Y., Bolotova N.

卷 16, 编号 1 (2014)

Clinical cases of treatment of hepatocellular carcinoma

Lazarev S., Mamontov K., Manihas G., Antimonik N.

卷 15, 编号 4 (2013)

RADIOTHERAPY AS THE ONLY TREATMENT IN CASE OF TONGUE CANCER PATIENTS

Garbuzov M.

卷 15, 编号 2 (2013)

The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion

Bagmet N., Bedzhanyan A., Polishchuk L., Sekacheva M., Shatveryan G., Skipenko O.

Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin

卷 10, 编号 4 (2008)

Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey

Rasner P., Pushkar' D., Govorov A.

Targetnaya terapiya raka pochki

Alekseev B., Shegay P.

Lekarstvennaya terapiya solidnykh opukholey s metastazami v golovnom mozge

Konstantinova M.

卷 8, 编号 1 (2006)

Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze

Nikitin E., Malakho S., Biderman B., Poltaraus A., Sudarikov A.

卷 26, 编号 4 (2024)

The role of ESR1 gene mutation in therapy selection for HR+/HER2- metastatic breast cancer: A review

Paichadze A., Chashnikova E., Golubeva S.

(Rus)

卷 25, 编号 4 (2023)

Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]

Yudina E.

(Rus)

Cabozantinib in the treatment of patients with advanced renal cell carcinoma

Volkova M., Turupaev K., Kalinin S.

(Rus)

卷 23, 编号 4 (2021)

The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021

Editorial B.

(Rus)

卷 23, 编号 3 (2021)

Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)

Kaprin A., Voronin E., Rassokhin V., Rozenberg V., Nekrasova A., Falaleeva N., Ivanov S., Grivtsova L.

(Rus)

The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor

Antiangiogenic therapy for breast cancer with triple negative phenotype

Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.

(Rus)

卷 21, 编号 4 (2019)

The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution

Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.

(Rus)

卷 20, 编号 2 (2018)

The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan

Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.

(Rus)

卷 19, 编号 1 (2017)

Ryazhenov V.

(Rus)

卷 18, 编号 1 (2016)

Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib

Sheko S., Dem'yanova G.

(Rus)

卷 17, 编号 1 (2015)

The role of targeted therapy in the treatment of advanced hepatocellular carcinoma

Shakhnovich E., Kerbikov O., Kulaga E.

卷 16, 编号 3 (2014)

Modern options in personalized therapy of metastatic cutaneous melanoma

Protsenko S., Novik A., Akhaeva Z., Zhabina A., Imyanitov E., Semenova A.

卷 16, 编号 2 (2014)

Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives

Alekseev B., Nyushko K., Kalpinskiy A., Kaprin A.

卷 15, 编号 3 (2013)

Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka

Timofeev I.

卷 15, 编号 1 (2013)

Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results

Garbuzov M.

Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey

Nikulin M., Stilidi I.

Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii

Konstantinova M.

Znachenie luchevoy terapii v lechenii generalizovannykh nekhodzhkinskikh limfom (IV stadiya)

Kharchenko V., Pan'shin G., Sotnikov V., Datsenko P., Smol'tsova N., Nikolaeva E.

卷 8, 编号 1 (2006)

Nekhodzhkinskie limfomy mochepolovoy sistemy

Bogdanov A., Maksimov A., Anosov N., Krivolapov Y.

卷 7, 编号 1 (2005)

Opyt primeneniya Regional'noy programmy v g. Krasnodare

Mitashok I.

卷 26, 编号 3 (2024)

New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision

Editorial B.

(Rus)

卷 25, 编号 4 (2023)

How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review

Zhukova L., Bordin D., Dubtsova E., Ilin M., Kiriukova M., Feoktistova P., Egorov V.

(Rus)

卷 25, 编号 1 (2023)

Can musical interventions benefit patients with cancer?

Razumovskaya E.

(Rus)

The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial

Volchegorskii I., Vazhenin A., Alekseeva A.

(Rus)

卷 23, 编号 2 (2021)

Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report

Protasova A., Strakh L., Lando E., Sidorkina E.

(Rus)

Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)

Ziganshin A.

(Rus)

卷 22, 编号 3 (2020)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.

(Rus)

卷 21, 编号 4 (2019)

Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children

Shervashidze M., Valiev T., Batmanova N., Tupitsyn N., Serebryakova I.

(Rus)

卷 20, 编号 1 (2018)

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.

(Rus)

卷 19, 编号 1 (2017)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer

Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.

(Rus)

卷 18, 编号 1 (2016)

The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options

Artamonova E., Manzyuk L.

(Rus)

卷 17, 编号 1 (2015)

Radiation-induced lung injury in breast cancer patients after breast conservation therapy

Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.

卷 16, 编号 2 (2014)

Angiogenesis as a target for cancer therapy

Imyanitov E.

卷 15, 编号 4 (2013)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)

Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.

卷 15, 编号 1 (2013)

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade

Lichinitser M., Semenov N.

卷 10, 编号 1 (2008)

Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii

Abuzarova G., Prokhorov B., Sokolenov A., Shakhnovich E.

Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey

Imyanitov E.